SMS Pharmaceuticals Limited — Board Meeting, 12-02-2025: Outcome of Board Meeting

The Board has approved the financial results for the quarter and nine months ended December 31, 2024. Consolidated revenue from operations stood at ₹173.35 crore for the quarter, and ₹534.55 crore for the nine months. The profit before tax for the quarter was ₹22.44 crore, leading to a net profit of ₹17.08 crore after tax expenses. The Board also approved the Company's Code for Regulation and Prohibition of Insider Trading policy, now available on the Company’s website.